For the F&A Next conference at Wageningen University next month, Anterra has selected seven food tech companies to pitch their novel technologies including logistics, gut microbiome testing, flavor analysis, novel milk proteins, and plant-based health products.
A lot of the questions surrounding the technology are not really scientific but about what this technology is feeding into: power politics, the changing structure of agriculture and smallholder farmers, and long-term effects.
THRIVE was voted Most Valuable Accelerator by the AgFunder network. It has built a platform to accelerate agrifood tech startup innovation by partnering with leading organizations and corporates across the agrifood and tech industries.
The British Government’s Food, Farming and Environment Minister, Michael Gove, has promised to deliver an ambitious new UK food strategy in 2019, embrace a properly funded 25-year environment plan and commit to rising investments in agritech.
“GMOs are an old, bludgeon tool that feels dated,” said Sam Kass, food entrepreneur, former White House chef and senior policy advisor for nutrition, founder of Trove, and venture partner in Acre Venture Partners.
Leading British politicians and AgriTech industry representatives met in the House of Commons in London this week to focus attention on the development of a £500 million ($650 million) AgriTech Cluster, to be located on the edge of the university town of Cambridge, in the UK.
“The problem with food waste is that it’s everyone’s responsibility, so it’s no one’s responsibility,” said Chris Cochran, executive director of ReFED, the multi-stakeholder nonprofit organization committed to reducing US food waste.
"Unless companies can solve supply chain issues and produce more food using novel tech, I don’t think the Chinese food industry will change tremendously,” Temasek's Anuj Maheshwari told delegates at 2050 China Food Tech Summit.
Christine Gould has been running the Thought for Food (TFF) Challenge and Summit for six years now. But this year a contest usually saturated with biotech and digital startups had an entirely different theme among its applicants.
While it was a positive first step that the FDA addressing the space, how it will play out is still uncertain as participants debated who should regulate the products, what it should be called, and how its safety will be determined.